The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

Share Price Information for Pressure Tech (PRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.50
Bid: 36.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 3.00 (8.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 37.50
PRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE ON TRADING AND COVID-19 IMPACT

9 Apr 2020 07:00

RNS Number : 2867J
Pressure Technologies PLC
09 April 2020
 

9 April 2020

PRESSURE TECHNOLOGIES plc

("Pressure Technologies" or "The Group")

UPDATE ON TRADING AND THE IMPACT OF COVID-19

 

Pressure Technologies (AIM: PRES), the specialist engineering group, provides an update on trading for the 26 weeks to 28 March 2020 and on the impact of COVID-19 on its operations.

Trading Update

Chesterfield Special Cylinders (CSC) performed in line with expectations for the half year. Progress with key energy and defence orders has continued in line with project plans. Sales growth for Integrity Management services continued in the period, despite the postponement of March deployments due to COVID-19 travel and access restrictions. As expected, operating profit for CSC will be lower than for the same period last year, due to the phasing of large contracts.

Precision Machined Components (PMC) achieved strong order intake over the past six months across a broadening customer base. Despite this progress, a significant delay to the output of new large complex components, the onboarding of new customers and the late commissioning of new machining centres adversely impacted gross margins in the first quarter. Recovery of output and margin performance in the second quarter was much slower than expected and, with higher indirect costs from the investment in sales and engineering functions, has resulted in a significantly lower operating profit on higher revenue than for the same period last year. However, margins and on-time delivery performance are improving as management changes and the ongoing programme of operational improvements, including recently implemented planning tools and systems, take effect.

As a result of contract phasing in CSC and delayed output in PMC, the unwinding of working capital and cash generation in the period has been slower than expected, resulting in a higher leverage at the half year than previously anticipated.

Good progress has been made against strategic priorities in both divisions, with continued broadening of the customer base in target markets. The investment made in strengthening the divisional sales teams and engineering capability has underpinned new customer acquisitions and an extended product range and scope. 

Outlook and the Impact of COVID-19

The Board is closely monitoring the changing global situation as a result of the COVID-19 pandemic.

Both divisions experienced some operational disruption and capacity issues during March as a result of COVID-19 restrictions and absences, but all sites remain open and operational and we are working on the basis of 'business as usual, with caution'. We will continually review this stance and adapt our approach in line with any changes to government guidelines and, more importantly, our ability to operate safely and effectively. 

Key customers of both CSC and PMC divisions have confirmed their status as supporting either UK Critical National Infrastructure or strategic defence contracts and requested our confirmation of continued operation during COVID-19 restrictions, subject to meeting UK government guidelines on workforce protection, which we have done.

Despite strong order books in both divisions at the half year, it remains difficult to predict the length and depth that the impact of COVID-19 will have on operational performance. This uncertainty is compounded by a depressed oil price and the Board anticipates that sales pipelines may be adversely affected, as some oil and gas customers defer project spend and apply pricing pressure throughout the supply chain. Both divisions remain in close contact with customers and suppliers and we will continue to take all appropriate steps to maintain business continuity and safely deliver customer orders. We are also communicating regularly and openly with all colleagues working on site, remotely and at home.

Given the level of uncertainty in the outlook, the Board has decided to withdraw guidance and forecasts. We continue to review possible scenarios and determine the actions we may take as the outlook becomes clearer. Management actions will seek to preserve cash and core capability in the business without undermining the progress already made in both divisions to establish resilience and a foundation for future growth in strategic focus areas.

We are in regular and constructive dialogue with Lloyds Bank regarding ongoing facility requirements and the impact of foreseeable COVID-19 disruption on operations and the leverage covenant. The Group's £12.0 million Revolving Credit Facility (RCF) is currently drawn at £9.3 million. We continue to evaluate government support measures available to the Group and will progress with actions and applications where appropriate. 

Chris Walters, Chief Executive of Pressure Technologies commented:

"While COVID-19 and a very low oil price present an uncertain outlook, I am confident that the management and operational changes already made over the past year will help the business to navigate through this challenging period and return to cash generative growth.

We have strong order books in both Chesterfield Special Cylinders and Precision Machined Components divisions and will endeavour to fulfil customer orders on time, while prioritising the safety and well-being of our employees as we all adapt to very different ways of working and living.

I am proud to see the tremendous commitment and continued hard work of our teams across the Group, those working on site, remotely and from home."

 

ENDS

 

For further information, please contact:

Pressure Technologies plc

Tel: 0114 257 3616

Chris Walters, Chief Executive

PressureTechnologies@houston.co.uk

Joanna Allen, Chief Financial Officer

N+1 Singer (Nomad and Broker)

 Tel: 0207 496 3000

Mark Taylor / Lauren Kettle

Houston (Financial PR and Investor Relations)

Tel: 0203 701 7660

Kate Hoare / Anushka Mathew

 

 

COMPANY DESCRIPTION

 

Company description - www.pressuretechnologies.com

With its head office in Sheffield, the Pressure Technologies Group was founded on its leading market position as a designer and manufacturer of high-integrity, safety-critical components and systems serving global supply chains in oil and gas, defence, industrial gases and hydrogen energy markets.

The Group has two divisions, Chesterfield Special Cylinders and Precision Machined Components.

Chesterfield Special Cylinders (CSC) - www.chesterfieldcylinders.com 

● Chesterfield Special Cylinders, Sheffield, includes CSC Deutschland GmbH and Chesterfield Special Cylinders Inc.

 

Precision Machined Components (PMC) - www.pt-pmc.com

● Precision Machined Components includes the Al-Met, Roota Engineering, Quadscot Precision Engineers and Martract brands.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGZGGDLRFGGZM
Date   Source Headline
27th Nov 20147:00 amRNSNotice of Preliminary Results
30th Oct 20147:00 amRNSIssue of Equity
20th Oct 20143:18 pmRNSHolding(s) in Company
17th Oct 20141:33 pmRNSIssue of Equity
1st Oct 20147:01 amRNSAcquisition of Quadscot Holdings Limited
1st Oct 20147:00 amRNSNew Bank Facilities
18th Sep 20147:00 amRNSAcquisition
1st Sep 201411:45 amRNSIssue of Equity
1st Aug 201411:25 amRNSGrant of Share Options
31st Jul 20148:00 amRNSTotal Voting Rights
21st Jul 20145:03 pmRNSDirector/PDMR Shareholding
11th Jul 201412:43 pmRNSAcquisition of shares by a Director
10th Jun 20147:00 amRNSHalf Yearly Report
30th May 20147:00 amRNSTotal Voting Rights
27th May 20147:00 amRNSNotice of Results
19th May 20147:00 amRNSIssue of Equity
4th Apr 20147:00 amRNSGrant of Share Options
31st Mar 20149:00 amRNSTotal Voting Rights
28th Mar 20149:47 amRNSHolding(s) in Company
12th Mar 20147:00 amRNSHolding(s) in Company
7th Mar 20141:10 pmRNSHolding(s) in Company
7th Mar 201412:04 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSAcquisition & Placing
13th Feb 20141:10 pmRNSResult of AGM
13th Feb 20147:00 amRNSAGM Statement
21st Jan 20147:00 amRNSContract win for Chesterfield BioGas
23rd Dec 20138:00 amRNSAnnual Financial Report
13th Dec 20137:00 amRNSStrategic Investment
3rd Dec 20137:00 amRNSPreliminary Results 2013
20th Nov 20138:00 amRNSAnalyst Briefing
23rd Oct 20137:00 amRNSNotice of Results and Trading Update
21st Aug 20137:00 amRNSContract wins for Chesterfield BioGas
20th Aug 201312:35 pmRNSHolding(s) in Company
9th Aug 201312:59 pmRNSDirector/PDMR Shareholding
9th Aug 201312:09 pmRNSGrant of Share Options
5th Aug 201312:26 pmRNSHolding(s) in Company
30th Jul 20137:00 amRNSGrant of Share Options
22nd Jul 201310:32 amRNSDirector/PDMR Shareholding
1st Jul 20135:29 pmRNSHolding(s) in Company
19th Jun 20132:13 pmRNSHolding(s) in Company
11th Jun 20137:02 amRNSBoard Appointment
11th Jun 20137:00 amRNSHalf Yearly Report
23rd May 201312:01 pmRNSNotice of Results and Analyst Briefing
18th Feb 20134:36 pmRNSHolding(s) in Company
14th Feb 20132:42 pmRNSHolding(s) in Company
12th Feb 201312:03 pmRNSResult of AGM
12th Feb 201310:12 amRNSBoard Changes
12th Feb 20137:00 amRNSTrading Update
7th Feb 201312:49 pmRNSHolding(s) in Company
1st Feb 20133:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.